Back to All Events

Pharmacy Compounding Advisory Committee

  • IQVIA Solutions Denmark A/S Denmark (map)

The Pharmacy Compounding Advisory Committee (PCAC) of the USFDA has scheduled a meeting on Wednesday, June 08, 2022. During the meeting, the committee will discuss the following four bulk drug substances nominated for inclusion on the 503A bulks list:
1. Ammonium Tetrathiomolybdate

2. Enclomiphene Citrate

3. Ferric Subsulfate

4. Glutathione

In addition, the FDA is considering whether to amend the rule to add lorcaserin hydrochloride and all drug products containing lorcaserin hydrochloride to the list.

Source:: https://www.fda.gov/advisory-committees/advisory-committee-calendar/june-8-2022-meeting-pharmacy-compounding-advisory-committee-meeting-announcement-06082022#event-materials
Earlier Event: June 7
Vaccines and Related Biological Products Advisory Committee
Later Event: June 9
Cellular, Tissue, and Gene Therapies Advisory Committee